Novartis signs agreement to acquire Anthos for $925m upfront
Pharmaceutical Technology
FEBRUARY 11, 2025
Novartis has agreed to acquire Anthos Therapeutics, a Boston-based clinical-stage biopharmaceutical company, for an upfront payment of $925m.
Pharmaceutical Technology
FEBRUARY 11, 2025
Novartis has agreed to acquire Anthos Therapeutics, a Boston-based clinical-stage biopharmaceutical company, for an upfront payment of $925m.
Bio Pharma Dive
FEBRUARY 10, 2025
The drug is cleared to treat complicated intra-abdominal infections, including those caused by tough-to-control, gram-negative bacteria.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
AuroBlog - Aurous Healthcare Clinical Trials blog
FEBRUARY 11, 2025
(koto_feja/E+/Getty Images) A new model of Alzheimer’s disease has been proposed, which could speed up efforts to understand and cure the complex condition while bringing all manifestations of the condition under one unifying theory.
Rethinking Clinical Trials
FEBRUARY 12, 2025
In this Friday’s PCT Grand Rounds, Angelo Volandes of Dartmouth Health and James Tulsky of Dana-Farber Cancer Institute will present “A Cluster Randomized, Stepped-Wedge Pragmatic Trial to Enhance Goals-of-Care Communication for Older Adults With Cancer (ACP-PEACE).” The Grand Rounds session will be held on Friday, February 14, 2025, at 1:00 pm eastern.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Medical Xpress
FEBRUARY 8, 2025
Pharmaceutical ads are difficult to avoid in American television programming and a growing number of them promote a class of medications called JAK inhibitors, using an acronym that assumes the average TV watcher knows exactly what JAK stands for.
Pharmaceutical Technology
FEBRUARY 11, 2025
Given the number of comorbidities associated with obesity, the market's growth will impact the entire cardiometabolic disease space.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
AuroBlog - Aurous Healthcare Clinical Trials blog
FEBRUARY 10, 2025
(Filipp Romanovski/Unsplash) If you look up at the sky on a clear day, you might notice little cobweb-like structures drifting across your field of vision.
Pharma Times
FEBRUARY 10, 2025
CSL Behring's study reveals significant long-term benefits
Medical Xpress
FEBRUARY 8, 2025
Mitochondria are essential for generating energy that fuels cells and helps them function.
Pharmaceutical Technology
FEBRUARY 12, 2025
Merck acquisition target SpringWorks will go toe-to-toe with AstraZeneca in the US neurofibromatosis market.
Bio Pharma Dive
FEBRUARY 13, 2025
Backed by Goldman Sachs, Novo Nordisk’s parent company and others, Newleos Therapeutics debuted Thursday with $94 million and a plan to develop drugs for brain function and health.
AuroBlog - Aurous Healthcare Clinical Trials blog
FEBRUARY 13, 2025
In the early hours of September 14 2021, three men parked in a quiet car park in the southern English market town of Abingdon-on-Thames. The men, returning from a night out, had pulled over to smoke heroin.
Pharma Times
FEBRUARY 10, 2025
New methodology may boost innovation in protein engineering
Medical Xpress
FEBRUARY 8, 2025
Years ago, a young patient's mother told Emily McCourt, MD, associate professor of ophthalmology at the University of Colorado School of Medicine, that she hadn't used a prescribed ointment to treat her baby's chemical corneal burn but instead used her own breast milk.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Pharmaceutical Technology
FEBRUARY 10, 2025
Tim Andrews underwent the procedure with the pig kidney as part of a three-person compassionate use study.
Bio Pharma Dive
FEBRUARY 10, 2025
Shares in the brain drug developer rose by more than 20% Monday on news of the deal, which will forestall Teva's generic copy of Auvelity from entering the U.S. market until at least 2038.
AuroBlog - Aurous Healthcare Clinical Trials blog
FEBRUARY 11, 2025
Indian pharmaceutical industry plays a crucial role in the global drug supply chain, particularly in the US. Yet India needs to develop strategies to mitigate the impact of USAID funding freeze for Indian pharma companies.
Pharma Times
FEBRUARY 13, 2025
Imaging agent to improve prostate cancer detection
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Medical Xpress
FEBRUARY 8, 2025
New research details the subcellular structures in neurons that enable signals to be transmitted from where they are received at specific sites on dendrites to the decision-making cell body located hundreds of micrometers away. The new research finds that the endoplasmic reticulum and the plasma membrane form contact sites where specialized molecules control the release of calcium, which regulates the signals sent along the dendrite to the soma.
Pharmaceutical Technology
FEBRUARY 10, 2025
Controversy surrounded Him & Hers commercial, called Sick of the System, in the lead up to Americas biggest sporting event.
Bio Pharma Dive
FEBRUARY 11, 2025
The acquisition of Anthos Therapeutics could be worth up to $3.1 billion and returns to Novartis a blood thinner it licensed to the Blackstone-backed startup six years ago.
AuroBlog - Aurous Healthcare Clinical Trials blog
FEBRUARY 12, 2025
(Dusty Pixel photography/Getty Images) An emerging strain of highly pathogenic avian influenza has spilled over from wild birds to dairy cows in the state of Nevada, and officials at the US Department of Agriculture (USDA) and some scientists are concerned by a mutation they are seeing. The viral variant, called genotype D1.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharma Times
FEBRUARY 12, 2025
UCB's BIMZELX reveals promising two-year data at EHSF 2025
pharmaphorum
FEBRUARY 13, 2025
The US Senate today confirmed Robert F Kennedy Jr as Health and Human Services Secretary, after a vote that largely followed party lines.
Pharmaceutical Technology
FEBRUARY 11, 2025
The World Health Organization and St Jude Children's Research Hospital have kicked off a programme to distribute cancer medicines to LMICs.
Bio Pharma Dive
FEBRUARY 14, 2025
Speaking this week at BIO CEO, the heads of Septerna, Upstream Bio and Actuate Therapeutics shared lessons from going public in a challenging market for biotech stocks.
Advertiser: FourKites
A research study conducted by The Journal of Commerce and FourKites surveyed hundreds of international shippers, exploring how their usage of global supply chain visibility technology has evolved since the onset of global disruptions caused by COVID-19. For international shippers, ocean freight visibility has evolved from optional to essential and satisfaction with visibility varies greatly depending on how it is obtained and delivered.
AuroBlog - Aurous Healthcare Clinical Trials blog
FEBRUARY 12, 2025
The proposed budget allocation for the Central sector schemes of Department of Health Research (DHR), under the ministry of health and family welfare, is expected see an increase of almost 40 per cent during the fiscal year 2025-26, as compared to the initial projects under the Budget Estimates (BE) for the fiscal year 2024-25.
JAMA Internal Medicine
FEBRUARY 9, 2025
This comparative effectiveness research study examines the outcomes of treatment with sodium-glucose cotransporter-2 inhibitors, glucagon-like peptide-1 receptor agonists, or dipeptidyl peptidase-4 inhibitors for patients with type 2 diabetes and chronic obstructive pulmonary disease.
pharmaphorum
FEBRUARY 10, 2025
AbbVie has won FDA approval for Emblaveo, a new antibiotic to treat pathogens that pose serious public health threats.
Pharmaceutical Technology
FEBRUARY 14, 2025
New EU regulations aim to speed up health technology assessments (HTAs), but the pharma industry raises logistical concerns.
Let's personalize your content